Підписатись
Disha Skelton-Badlani
Disha Skelton-Badlani
Beth Israel Deaconess Medical Centre/ Harvard Medical School
Підтверджена електронна адреса в bidmc.harvard.edu
Назва
Посилання
Посилання
Рік
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c. Abcb4-/-mouse model of PFIC3
G Wei, J Cao, P Huang, P An, D Badlani, KA Vaid, S Zhao, DQH Wang, ...
Journal of hepatology 74 (6), 1416-1428, 2021
512021
Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis
MR Ingrosso, M Camilleri, J Tack, G Ianiro, CJ Black, AC Ford
Gastroenterology 164 (4), 642-654, 2023
392023
Circulating mitochondrial DNA as a diagnostic biomarker for predicting disease severity in patients with acute pancreatitis
W Yakah, I Shah, D Skelton-Badlani, SD Freedman, YV Popov, SG Sheth, ...
Gastroenterology 164 (6), 1009-1011. e3, 2023
82023
Metabolic hijacking of hexose metabolism to ascorbate synthesis is the unifying biochemical basis of murine liver fibrosis
D Beyoğlu, P Huang, D Skelton-Badlani, C Zong, YV Popov, JR Idle
Cells 12 (3), 485, 2023
72023
Automated whole slide image analysis for a translational quantification of liver fibrosis
C Serdjebi, K Bertotti, P Huang, G Wei, D Skelton-Badlani, IA Leclercq, ...
Scientific reports 12 (1), 17935, 2022
72022
A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients
Y Pita-Juarez, D Karagkouni, N Kalavros, JC Melms, S Niezen, ...
BioRxiv, 2022
72022
ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer
Z Peng, G Wei, P Huang, H Matta, W Gao, P An, S Zhao, Y Lin, L Tan, ...
Hepatology 80 (2), 346-362, 2024
12024
ASK1/p38 AXIS INHIBITION BLOCKS THE RELEASE OF MITOCHONDRIAL" DANGER SIGNALS" FROM HEPATOCYTES AND SUPPRESSES PROGRESSION TO CIRRHOSIS AND LIVER CANCER
Z Peng, G Wei, P Huang, P An, S Zhao, Y Lin, L Tan, K Vaid, ...
Hepatology 78, S1514-S1514, 2023
12023
Transposon-based oncogene integration in Abcb4 (Mdr2)-/-mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis
P Huang, G Wei, JD Kirkpatrick, Y Lin, L Tan, H Matta, I Nasser, M Huang, ...
Journal of hepatology 82 (1), 84-96, 2025
2025
PLASMA CELL-FREE MTDNA IS RELEASED IN ALCOHOL-RELATED LIVER DISEASE AND CORRELATES WITH LIVER INJURY
M Alenzi, P Huang, H Matta, D Badlani, DG Ojeda, G Horta, M Lai, ...
HEPATOLOGY 80, 2024
2024
THU-322-YI Plasma cell-free mtDNA is released in alcohol-associated liver disease and correlates with liver injury
M Alenzi, G Wen, H Matta, P Huang, D Badlani, DG Ojeda, G Horta, M Lai, ...
Journal of Hepatology 80, S129, 2024
2024
TGFbeta2 UPREGULATION ON REACTIVE CHOLANGIOCYTES LIMITS THE THERAPEUTIC EFFICACY OF TGFbeta TRAP RAP-1332 IN MOUSE MODELS OF CHRONIC BILIARY INJURY AND FIBROSIS
P Huang, M Shipman, D Skelton-Badlani, R Chen, S Suragani, P Andre, ...
HEPATOLOGY 78, S1532-S1533, 2023
2023
SELECTIVE TARGETING OF INTEGRIN avbeta8 EFFECTIVELY SUPPRESSES TUMOR GROWTH IN THE NEW PSC-ASSOCIATED CHOLANGIOCARCINOMA MODEL (SB CCA. Mdr2-/-MOUSE)
P Huang, W Gao, H Matta, D Skelton-Badlani, N Blanco, M Lu, B Lippa, ...
HEPATOLOGY 78, S1951-S1952, 2023
2023
1007 MITOCHONDRIAL DNA CIRCULATES IN THE SERUM OF PATIENTS WITH ALCOHOLIC LIVER DISEASE AND REFLECTS ONGOING LIVER INJURY
MM ALENZI, D Skelton-Badlani, P Huang, ZG Jiang, Y Popov
Gastroenterology 164 (6), S-1269-S-1270, 2023
2023
Tu1415 CIRCULATING MITOCHONDRIAL DNA IN ACUTE PANCREATITIS: A POTENTIAL EARLY NON-INVASIVE BIOMARKER FOR PREDICTING DISEASE SEVERITY?
I Shah, W Yakah, D Skelton-Badlani, A Chhoda, P Huang, A Ahmed, ...
Gastroenterology 164 (6), S-1047, 2023
2023
A SINGLE-NUCLEUS AND SPATIAL TRANSCRIPTOMICS ATLAS REVEALS SUB-CLINICAL BUT MAJOR TOPOLOGICAL, FUNCTIONAL, AND REGENERATIVE LIVER DISRUPTION IN PATIENTS WITH SEVERE COVID-19
ZG Jiang, Y Pita-Juarez, J Hecht, S Niezen, A Myloserdnyy, D Karagkouni, ...
HEPATOLOGY 76, S72-S73, 2022
2022
SPATIAL TRANSCRIPTOMICS REVEALS EXTENSIVE CELLULAR RESTRUCTURING AND THE TRANSCRIPTIONAL LANDSCAPE IN PRIMARY SCLEROSING CHOLANGITIS
Y Pita-Juarez, L Martelotto, N Kalavros, A Ploumakis, D Badlani, P Huang, ...
HEPATOLOGY 76, S197-S198, 2022
2022
TIME-EFFICIENT AND RELIABLE AUTOMATED LIVER FIBROSIS QUANTIFICATION IN PRECLINICAL FIBROSIS MODELS USING WHOLE SLIDE IMAGING
C Serdjebi, K Bertotti, P Huang, G Wei, D Badlani, D Barbes, B Lepoivre, ...
HEPATOLOGY 74, 1095A-1096A, 2021
2021
SB CCA. Mdr2-/-, A NEW MOUSE MODEL OF CHOLANGIOCARCINOMA ARISING IN THE PSC-LIKE SETTINGS OF PROGRESSIVE BILIARY INJURY AND FIBROSIS
P Huang, G Wei, S Zhao, D Badlani, K Vaid, L Chen, MM Petitjean, ...
HEPATOLOGY 74, 712A-712A, 2021
2021
Newmouse model of cholangiocarcinoma arising in the setting of progressive biliary injury and fibrosis
P Huang, G Wei, S Zhao, D Badlani, L Chen, M Petitjean, X Chen, ...
JOURNAL OF HEPATOLOGY 75, S499-S500, 2021
2021
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20